MENU
ONC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BeOne Medicines (ONC) Earnings Date & Reports

Formerly known as BeiGene and founded in 2010 in Beijing, BeOne is a commercial-stage biotech firm that produces oncology therapeutics... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ONC is expected to report earnings to fall 6.83% to $1.91 per share on November 05

BeOne Medicines ONC Stock Earnings Reports
Q3'26
Est.
$1.91
Q2'26
Beat
by $0.50
Q1'26
Beat
by $0.95
Q4'25
Beat
by $0.42
Q3'25
Beat
by $1.85
The last earnings report on August 05 showed earnings per share of $2.05, beating the estimate of $1.55. With 195.25K shares outstanding, the current market capitalization sits at 41.82B.
View a ticker or compare two or three
ONC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceutical products

Industry Biotechnology

Industry
Biotechnology
Address
c/o BeOne Medicines I GmbH
Phone
+41 616851900
Employees
12000
Web
https://www.beonemedicines.com